RXRX
RXRX
US75629V1044
Recursion Pharmaceuticals, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
2.34B EUR
1.96B EUR
1.63B EUR
2.16B EUR
Enterprise Value
1.64B EUR
1.48B EUR
1.05B EUR
1.49B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-4.83x
--
--
--
Price to Sales
42.62x
36.34x
24.78x
36.35x
Price to Book
2.55x
2.14x
1.59x
1.91x
EV/Revenue
29.82x
27.46x
15.93x
25.15x
EV/EBITDA
-3.47x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-9.39%
-18.07%
-20.14%
-11.42%
ende